Baş ve Boyun, Mukozal, Diş ve Yumuşak Doku Sorunları
Özet
Baş ve boyun bölgesi kanser tedavisi sonrası takip sürecinde en sık karşılaşılan sorunlardan biri mukozal, diş ve yumuşak doku komplikasyonlarıdır. Özellikle radyoterapi ve kemoterapi gibi tedaviler, oral mukozada ülserasyon, kuruluk (kserostomi), tat alma bozuklukları ve enfeksiyonlara neden olabilir. Mukozit, tedavi sürecinin erken dönemlerinde sık görülürken, geç dönemde ise kserostomi ve buna bağlı dental problemler (diş çürükleri, periodontal hastalıklar) öne çıkar.
Radyoterapiye bağlı olarak gelişen hasarlar ağız kuruluğuna ve buna bağlı yumuşak doku yaralanmalarına zemin hazırlar. Ayrıca, ağız hijyeninin bozulması enfeksiyon riskini artırır. Diş sağlığının korunması bu nedenle kritik öneme sahiptir; tedavi öncesi dişlerin değerlendirilmesi ve tedavi sonrası düzenli ağız-diş bakımı, osteoradyonekroz gibi ciddi komplikasyonların önlenmesinde rol oynar.
Yumuşak doku fibrozisi ve trismus (çene açıklığında azalma), hem beslenmeyi hem de günlük yaşam aktivitelerini etkileyebilir. Kanser hasta takibinde sadece tümör nüksü değil; aynı zamanda oral ve dental sağlığın korunması, beslenme desteği, psikososyal destek ve multidisipliner bir yaklaşım da esastır. Tedavi öncesi ve sonrası diş hekimi kontrolü, hastaya uygun ağız bakımı eğitimi ve düzenli kontrol ziyaretleri, komplikasyonların önlenmesinde kritik rol oynar.
Bu bölümde kanser tedavisine bağlı gelişen mukozal, dişsel ve yumuşak doku problemleri ele alınarak, kanser takibinde bu problemleri tanıma, önleme ve tedavi yaklaşımları güncel literatür ışığında tartışılacaktır.
One of the most common complications encountered during the follow-up period after head and neck cancer treatment is mucosal, dental, and soft tissue damage. Radiotherapy and chemotherapy can lead to oral mucosal ulceration, xerostomia, dysgeusia, and infections. While mucositis is more prevalent in the early stages of treatment, xerostomia and associated dental problems such as tooth decay and periodontal disease become more prominent in the later stages. Radiation-induced damage to the salivary glands predisposes patients to soft tissue injuries and increases the risk of osteoradionecrosis.
Soft tissue fibrosis and trismus can impair nutrition and speech, significantly reducing quality of life. Therefore, cancer follow-up should not only aim to detect tumor recurrence, but also to maintain oral and dental health, ensure adequate oral hygiene, and provide nutritional and psychosocial support. Pre-treatment dental evaluations, post-treatment oral care education, and routine follow-up visits play a crucial role in preventing such complications.
In this context, mucosal, dental, and soft tissue complications arising from cancer therapy must be recognized, prevented, and managed using up-to-date, multidisciplinary approaches based on current literature.
Referanslar
Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453–61. doi:10.1002/cncr.28592
Dahners LE, Nix LC, McNamara KO, et al. Soft tissue fibrosis after radiation therapy: pathophysiology and current management. J Otolaryngol Head Neck Surg. 2019;48(1):35.
CTCAE v5.0 – Common Terminology Criteria for Adverse Events. U.S. Department of Health and Human Services, National Cancer Institute; 2017.
National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers, Version 2.2024.
Pignon JP, le Maître A, Maillard E, et al; MACH-NC Collaborative Group. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92(1):4–14.
Wolf GT, Fisher SG, Hong WK, et al; Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991;324(24):1685–1690.
Furness S, Glenny AM, Worthington HV, et al; CSROC Expert Panel. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy. Cochrane Database Syst Rev 2010;(9):CD006386. [Published update appears in Cochrane Database Syst Rev 2011;(4):CD006386.]
Berger AM, Kilroy TJ. Oral complications. In: DeVita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: principles and practice of oncology. Philadelphia, PA: Lippincott-Raven, 1997; 2714–2725.
Rao D, Behzadi F, Le RT, et al. Radiation induced mucositis: what the radiologist needs to know. Curr Probl Diagn Radiol 2021;50(6):899–904.
Bowen J, Al-Dasooqi N, Bossi P, et al.: The pathogenesis of mucositis: updated perspectives and emerging targets. Support Care Cancer 27 (10): 4023-4033, 2019.
Mougeot JC, Stevens CB, Morton DS, et al.: Oral Microbiome and Cancer Therapy-Induced Oral Mucositis. J Natl Cancer Inst Monogr 2019 (53): , 2019.
Sonis ST: Oral mucositis in head and neck cancer: risk, biology, and management. Am Soc Clin Oncol Educ Book : , 2013.
Holländer-Mieritz C, Johansen J, Johansen C, et al.: Comparing the patients' subjective experiences of acute side effects during radiotherapy for head and neck cancer with four different patient-reported outcomes questionnaires. Acta Oncol 58 (5): 603-609, 2019.
Jones JA, Chavarri-Guerra Y, Corrêa LBC, et al.: MASCC/ISOO expert opinion on the management of oral problems in patients with advanced cancer. Support Care Cancer 30 (11): 8761-8773, 2022.
Hunter M, Kellett J, Toohey K, et al.: Toxicities Caused by Head and Neck Cancer Treatments and Their Influence on the Development of Malnutrition: Review of the Literature. Eur J Investig Health Psychol Educ 10 (4): 935-949, 2020.
Pedersen AML, Sørensen CE, Proctor GB, et al.: Salivary secretion in health and disease. J Oral Rehabil 45 (9): 730-746, 2018
Spijkervet FKL, Schuurhuis JM, Stokman MA, et al.: Should oral foci of infection be removed before the onset of radiotherapy or chemotherapy? Oral Dis 27 (1): 7-13, 2021.
Castagnola E, Mikulska M, Viscoli C: Prophylaxis and Empirical Therapy of Infection in Cancer Patients. In: Bennett JE, Dolin R, Blaser MJ, eds.: Principles and Practice of Infectious Diseases. 8th ed.: Elsevier, Inc., 2015, Elsevier, Inc., 2015, pp 3395-413. Available online. Last accessed October 10, 2023
Ohbayashi Y, Imataki O, Uemura M, et al.: Oral microorganisms and bloodstream infection in allogeneic hematopoietic stem cell transplantation. Clin Oral Investig 25 (7): 4359-4367, 2021.
Hellstein JW, Marek CL: Candidiasis: Red and White Manifestations in the Oral Cavity. Head Neck Pathol 13 (1): 25-32, 2019.
Singh GK, Capoor MR, Nair D, et al.: Spectrum of fungal infection in head and neck cancer patients on chemoradiotherapy. J Egypt Natl Canc Inst 29 (1): 33-37, 2017.
Cheong HS, Kim SY, Ki HK, et al.: Oral mucormycosis in patients with haematologic malignancies in a bone marrow transplant unit. Mycoses 60 (12): 836-841, 2017.
Elad S, Zadik Y, Hewson I, et al.: A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea. Support Care Cancer 18 (8): 993-1006, 2010.
Schubert MM, Correa MEP, Peterson DE: Oral complications of hematopoietic cell transplantation. In: Forman SJ, Negrin RS, Antin JH, et al., eds.: Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation. 5th ed. John Wiley & Sons, Ltd, 2016, pp 1242-56.
Donnelly JP, De Pauw BE. Infections in the immunocompromised host. In: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Elsevier; 2015. p. 3405–3417.
Peterson DE, Boers-Doets CB, Bensadoun RJ, Herrstedt J. Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines. Ann Oncol. 2015;26(Suppl 5):v139–v151.
Adjei Boakye E, Buchanan P, Hinyard L, et al.: Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy. Laryngoscope 129 (8): 1828-1835, 2019
Brands MT, Smeekens EAJ, Takes RP, et al.: Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer. Cancer Med 8 (12): 5810-5819, 2019.
Rocha PHP, Reali RM, Decnop M, et al. Adverse radiation therapy effects in the treatment of head and neck tumors. RadioGraphics 2022;42(3):806–821.
Sroussi HY, Epstein JB, Bensadoun RJ, et al. Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunction, dental caries, and osteoradionecrosis. Cancer Med. 2017;6(12):2918–2931. doi:10.1002/cam4.1221
Bharatha A, Yu E, Symons SP, Bartlett ES. Pictorial essay: early- and late-term effects of radiotherapy in head and neck imaging. Can Assoc Radiol J 2012;63(2):119–128.
Saito N, Nadgir RN, Nakahira M, et al. Posttreatment CT and MR imaging in head and neck cancer: what the radiologist needs to know. RadioGraphics 2012;32(5):1261–1282; discussion 1282–1284.
Fu KK, Woodhouse RJ, Quivey JM, Phillips TL, Dedo HH. The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord. Cancer 1982;49(4):655–658.
Rancati T, Schwarz M, Allen AM, et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S64–S69.
Nguyen NP, Abraham D, Desai A, et al. Impact of image-guided radiotherapy to reduce laryngeal edema following treatment for non-laryngeal and non-hypopharyngeal head and neck cancers. Oral Oncol 2011;47(9):900–904.
Teshima K, Murakami R, Tomitaka E, et al. Radiation-induced parotid gland changes in oral cancer patients: correlation between parotid volume and saliva production. Jpn J Clin Oncol 2010;40(1):42–46.
Sciubba JJ, Goldenberg D. Oral complications of radiotherapy. Lancet Oncol 2006;7(2):175–183.
Peterson DE, Doerr W, Hovan A, et al. Osteoradionecrosis in cancer patients: the evidence base for treatment-dependent frequency, current management strategies, and future studies. Support Care Cancer 2010;18(8):1089–1098.
Reuther T, Schuster T, Mende U, Kübler A. Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients--a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 2003;32(3):289–295.
Hermans R. Imaging of mandibular osteoradionecrosis. Neuroimaging Clin N Am 2003;13(3):597–604.
Chong J, Hinckley LK, Ginsberg LE. Masticator space abnormalities associated with mandibular osteoradionecrosis: MR and CT findings in five patients. AJNR Am J Neuroradiol 2000;21(1):175–178
Stell PM, Morrison MD. Radiation necrosis of the larynx. Etiology and management. Arch Otolaryngol Head Neck Surg 1973;98(2):111–113
Halkud R, Shenoy AM, Naik SM, et al.n Chondroradionecrosis of larynx a delayed complication of radiotherapy: management and review of literature. Indian J Surg Oncol 2014;5(2):128–133.
Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM. CT findings in chondroradionecrosis of the larynx. AJNR Am J Neuroradiol 1998;19(4):711–718.
Chuang SK, Tian L, Wei L, et al. Osteoradionecrosis and primary tumor recurrence in patients with oral cancer: a competing risk analysis. Head Neck. 2020;42(4):687–696. doi:10.1002/hed.26019
Herrmann J. Vascular toxic effects of cancer therapies. Nat Rev Cardiol 2020;17(8):503
Becker M, Schroth G, Zbären P, et al. Long-term changes induced by high-dose irradiation of the head and neck region: imaging findings. RadioGraphics 1997;17(1):5–26.
Rabin BM, Meyer JR, Berlin JW, Marymount MH, Palka PS, Russell EJ. Radiation-induced changes in the central nervous system and head and neck. RadioGraphics 1996;16(5):1055–1072.
Paydarfar JA, Birkmeyer NJ. Complications in head and neck surgery: a meta-analysis of postlaryngectomy pharyngocutaneous fistula. Arch Otolaryngol Head Neck Surg 2006;132(1):67–72.
Giordano AM Jr, Cohen J, Adams GL. Pharyngocutaneous fistula after laryngeal surgery: the role of the barium swallow. Otolaryngol Head Neck Surg 1984;92(1):19–23.
Arlen M, Higinbotham NL, Huvos AG, Marcove RC, Miller T, Shah IC. Radiation-induced sarcoma of bone. Cancer 1971;28(5):1087–1099.
Khanna L, Prasad SR, Yedururi S, et al. Second malignancies after radiation therapy: update on pathogenesis and cross-sectional imaging findings. RadioGraphics 2021;41(3):876–894.
Goldman SM, Hartman DS, Weiss SW. The varied radiographic manifestations of retroperitoneal malignant fibrous histiocytoma revealed through 27 cases. J Urol 1986;135(1):33–38.
Michot JM, Bigenwald C, Champiat S, et al.: Immune-related adverse events with immune checkpoint blockade: a comprehensive review. Eur J Cancer 54: 139-148, 2016.
Wang PF, Chen Y, Song SY, et al.: Immune-Related Adverse Events Associated with Anti-PD-1/PD-L1 Treatment for Malignancies: A Meta-Analysis. Front Pharmacol 8: 730, 2017.
Park H, Hata A, Hatabu H, Ricciuti B, Awad M, Nishino M. Immune-related thyroiditis in patients with advanced lung cancer treated with immune checkpoint inhibitors: imaging features and clinical implications. Cancers (Basel) 2023;15(3):649.
Chalan P, Di Dalmazi G, Pani F, De Remigis A, Corsello A, Caturegli P. Thyroid dysfunctions secondary to cancer immunotherapy. J Endocrinol Invest 2018;41(6):625–638.
Baraka B, Abosheaishaa H, Nassar M. Immunotherapy-induced thyroid dysfunction: an updated review. Egypt J Intern Med 2023;35(1):48.
González-Rodríguez E, Rodríguez-Abreu D;Spanish Group for Cancer Immuno-Biotherapy (GETICA). Immune checkpoint inhibitors: review and management of endocrine adverse events. Oncologist 2016;21(7):804–816.
Vigarios E, Epstein JB, Sibaud V: Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer 25 (5): 1713-1739, 2017.
Nikolaou V, Voudouri D, Tsironis G, et al.: Cutaneous toxicities of antineoplastic agents: data from a large cohort of Greek patients. Support Care Cancer 27 (12): 4535-4542, 2019.
Al-Dasooqi, N., Sonis, S.T., Bowen et al. (2013). Emerging evidence on the pathobiology of mucositis. Support Care Cancer, 21(7), 2075–2083. doi: https://doi.org/10.1007/s00520-013-1810-y
Kusiak, A., Jereczek-Fossa, B.A., Cichońska et al. (2020). Oncological-therapy related oral mucositis as an ınterdisciplinary problem—literature review. International Journal of Environmental Research and Public Health, 17(7), 2464. doi: https://doi.org/10.3390/ijerph17072464
Hong, C.H.L., Gueiros, L.A., Fulton et al. (2019). Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer, 27(10), 3949-3967. doi: https://doi.org/10.1007/s00520-019-04848-4
Saunders DP, Epstein JB, Elad S, et al.: Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 21 (11): 3191-207, 2013.
Riley P, Glenny AM, Worthington HV, et al.: Interventions for preventing oral mucositis in patients with cancer receiving treatment: oral cryotherapy. Cochrane Database Syst Rev 2015 (12): CD011552, 2015.
Zadik Y, Arany PR, Fregnani ER, et al.: Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27 (10): 3969-3983, 2019.
Yarom N, Hovan A, Bossi P, et al.: Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. Support Care Cancer 27 (10): 3997-4010, 2019.
Keefe DM, Schubert MM, Elting LS, et al.: Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109 (5): 820-31, 2007.
Villa A, Wolff A, Narayana N, et al.: World Workshop on Oral Medicine VI: a systematic review of medication-induced salivary gland dysfunction. Oral Dis 22 (5): 365-82, 2016. [PUBMED Abstract]
Adel N: Overview of chemotherapy-induced nausea and vomiting and evidence-based therapies. Am J Manag Care 23 (14 Suppl): S259-S265, 2017.
Hovan AJ, Williams PM, Stevenson-Moore P, et al.: A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18 (8): 1081-7, 2010.
Epstein JB, Smutzer G, Doty RL: Understanding the impact of taste changes in oncology care. Support Care Cancer 24 (4): 1917-31, 2016.
Barbosa da Silva JL, Doty RL, Miyazaki JVMK, et al.: Gustatory disturbances occur in patients with head and neck cancer who undergo radiotherapy not directed to the oral cavity. Oral Oncol 95: 115-119, 2019.
Jensen, S. B., Pedersen, A. M. L., Vissink, A et al. (2010). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Supportive Care in Cancer, 18(8), 1061–1079. https://doi.org/10.1007/s00520-010-0837-6
Vissink, A., Jansma, J., Spijkervet, F. K. Et al. (2003). Oral sequelae of head and neck radiotherapy. Critical Reviews in Oral Biology & Medicine, 14(3), 199–212. https://doi.org/10.1177/154411130301400305
Lalla, R. V., Bowen, J., Barasch, A., et al. (2014). MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer, 120(10), 1453–1461. https://doi.org/10.1002/cncr.28592
Katsura K, Sasai K, Sato K, et al. Relationship Between Oral Health Status And Development Of Osteoradionecrosis Of The Mandible: A Retrospective Longitudinal Study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Jun;105(6):731-8. Doi: 10.1016/J.Tripleo.2007.10.011. Epub 2008 Mar 10.
Taichman Ls, Van Poznak Ch, Inglehart Mr. Self-Reported Oral Health And Quality Of Life Of Postmenopausal Breast Cancer Survivors On Aromatase Inhibitors And Women Without Cancer Diagnoses: A Longitudinal Analysis. Support Care Cancer. 2016 Nov;24(11):4815-24. Doi: 10.1007/S00520-016-3336-6. Epub 2016 Jul 25.
Decker, A.M., Taichman, L.S., D’silva, N.J. et Al. Periodontal Treatment In Cancer Patients: An Interdisciplinary Approach. Curr Oral Health Rep 5, 7–12 (2018).
Shapiro CL, Van Poznak C, Lacchetti C, et al.: Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: ASCO Clinical Practice Guideline. J Clin Oncol 37 (31): 2916-2946, 2019.
Smidt-Hansen T, Folkmar TB, Fode K, et al.: Combination of zoledronic Acid and targeted therapy is active but may induce osteonecrosis of the jaw in patients with metastatic renal cell carcinoma. J Oral Maxillofac Surg 71 (9): 1532-40, 2013.
Ruggiero SL, Dodson TB, Fantasia J, et al.: American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg 72 (10): 1938-56, 2014.
Yarom N, Shapiro CL, Peterson DE, et al.: Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. J Clin Oncol 37 (25): 2270-2290, 2019.
El-Rabbany M, Sgro A, Lam DK, et al.: Effectiveness of treatments for medication-related osteonecrosis of the jaw: A systematic review and meta-analysis. J Am Dent Assoc 148 (8): 584-594.e2, 2017.
Kaste SC, Goodman P, Leisenring W, et al.: Impact of radiation and chemotherapy on risk of dental abnormalities: a report from the Childhood Cancer Survivor Study. Cancer 115 (24): 5817-27, 2009.
Langendijk, J. A., Doornaert, P., Verdonck-de Leeuw, at al. (2010). Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. Journal of Clinical Oncology, 26(22), 3770–3776. https://doi.org/10.1200/JCO.2007.14.6647
van der Molen, L., van Rossum, M. A., Ackerstaff, et al. (2009). Pretreatment organ function in patients with advanced head and neck cancer: clinical outcome measures and patients’ views. BMC Ear, Nose and Throat Disorders, 9(1), 10. https://doi.org/10.1186/1472-6815-9-10
Schubert MM, Correa MEP, Peterson DE: Oral complications of hematopoietic cell transplantation. In: Forman SJ, Negrin RS, Antin JH, et al., eds.: Thomas’ Hematopoietic Cell Transplantation: Stem Cell Transplantation. 5th ed. John Wiley & Sons, Ltd, 2016, pp 1242-56.
Hong CHL, Gueiros LA, Fulton JS, et al.: Systematic review of basic oral care for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer 27 (10): 3949-3967, 2019.
Epstein JB, Smutzer G, Doty RL: Understanding the impact of taste changes in oncology care. Support Care Cancer 24 (4): 1917-31, 2016.
Elad S, Raber-Durlacher JE, Brennan MT, et al.: Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer 23 (1): 223-36, 2015.
Rapoport BL, van Eeden R, Sibaud V, et al. Supportive care for patients undergoing immunotherapy. Support Care Cancer 25 (10): 3017-3030, 2017.
Stubblefield MD, Manfield L, Riedel ER. A preliminary report on the effect of a targeted exercise program on shoulder dysfunction in head and neck cancer survivors. Arch Phys Med Rehabil. 2010;91(10):1584–1588. doi:10.1016/j.apmr.2010.06.022
Baker SR, Le QT, Bhattacharyya N. Head and Neck Cancer: A Multidisciplinary Approach. Springer International Publishing
Gillivan-Murphy, P., Carding, P. N., Miller et al. (2011). Psychosocial effects of dysphonia during and after head and neck cancer. Journal of Voice, 25(4), 473–482. https://doi.org/10.1016/j.jvoice.2010.07.003
Kamstra, J. I., Jager-Wittenaar, H., Dijkstra, P. U., & van der Laan, B. F. A. M. (2017). Jaw function deterioration in patients with head and neck cancer: A prospective 2-year study. Head & Neck, 39(9), 1851–1860. https://doi.org/10.1002/hed.24836
Jager-Wittenaar, H., & Ottery, F. D. (2017). Nutrition in head and neck cancer patients: state of the art. Cancers of the Head & Neck, 2(1), 1–12. https://doi.org/10.1186/s41199-016-0013-1
